Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot-Reference-Cited by-同舟云学术

Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot

Published:2019-10-31 Issue:6 Volume:14 Page:647-657
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Hirve Siddhivinayak¹^ORCID,Crawford Nigel²,Palekar Rakhee³,Zhang Wenqing¹,Bancej Christina,Barr Ian,Baumeister Elsa,Broor Shobha,Burmaa Alyeksandr,Campbell Harry,Caetano Braulia,Chadha Mandeep,Chittaganpitch Malinee,Coulibaly Daouda,Darmaa Badarch,Ellis Joanna,Fahim Manal,Fasce Rodrigo,Herve Kadjo,Jackson Sandra,Pisareva Maria,Moyes Jocelyn,Naguib Amel,Nair Harish,Pebody Richard,Potdar Varsha,Rajatonirina Soatiana,Siqueira Marilda,Smith Peter G.,Smorodintseva Elizaveta,Sotomayor Viviana,Treurnicht Florette,Tivane Almiro,Venter Marietjie,Wairagkar Niteen,Zambon Maria,

Affiliation:

1. Global Influenza Programme World Health Organization Geneva Switzerland

2. Royal Children's Hospital Melbourne Vic. Australia

3. Pan American Health Organization Washington DC USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12688

Reference30 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

2. PATH The global respiratory syncytial virus burden ‐ a summary of the latest estimates.2018.

3. PATH.RSV vaccine and mAb snapshot.2018.https://vaccineresources.org/details.php?i=1562. Accessed October 16 2018.

4. Respiratory Syncytial Virus Infection in Adults

5. Respiratory syncytial virus infection in elderly and high‐risk adults;Falsey AR;Exp Lung Res,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe respiratory syncytial virus disease;Journal of Intensive Medicine;2024-10

2. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies;The Lancet;2024-09

3. Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis;2024-08-07

4. Risk factors and circulation pattern of respiratory syncytial virus in children under 2 years in Maputo, Mozambique;International Health;2024-05-08

5. What ‘case definition’ for respiratory syncytial virus infection? Results of a systematic literature review to improve surveillance among the adults;Journal of Public Health;2024-05-05